Key result
α-actinin-4 (ACTN4) regulates cancer invasiveness by controlling non-muscle myosin IIB expression and non-muscle myosin IIA localization.
Why the study?
The mechanisms by which the mechanoresponsive actin crosslinking protein alpha-actinin-4 (ACTN4) regulates cell motility and invasiveness remain incompletely understood.
Answers are grounded in this paper and cite their sources.
The mechanisms by which the mechanoresponsive actin crosslinking protein α-actinin-4 (ACTN4) regulates cell motility and invasiveness remain incompletely understood. Here, we show that, in addition to regulating protrusion dynamics and focal adhesion formation, ACTN4 transcriptionally regulates expression of non-muscle myosin IIB (NMM IIB; heavy chain encoded by MYH10), which is essential for mediating nuclear translocation during 3D invasion. We further show that an indirect association between ACTN4 and NMM IIA (heavy chain encoded by MYH9) mediated by a functional F-actin cytoskeleton is essential for retention of NMM IIA at the cell periphery and modulation of focal adhesion dynamics. A protrusion-dependent model of confined migration recapitulating experimental observations predicts a dependence of protrusion forces on the degree of confinement and on the ratio of nucleus to matrix stiffness. Together, our results suggest that ACTN4 is a master regulator of cancer invasion that regulates invasiveness by controlling NMM IIB expression and NMM IIA localization. This article has an associated First Person interview with the first author of the paper.
No takes yet. Share an insight, caveat, or question.
Barai et al. (2021) studied Cancer invasion. α-actinin-4 (ACTN4) was evaluated. α-actinin-4 (ACTN4) regulates cancer invasiveness by controlling non-muscle myosin IIB expression and non-muscle myosin IIA localization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: